发明名称 |
Cardiac muscle regeneration using mesenchymal stem cells |
摘要 |
Disclosed is a method for producing cardiomyocytes in vivo by administering to the heart of an individual a cardiomyocyte producing amount of mesenchymal stem cells. These cells can be administered as a liquid injectible or as a preparation of cells in a matrix which is or becomes solid or semi-solid. The cells can be genetically modified to enhance myocardial differentiation and integration. Also disclosed is a method for replacing cells ex vivo in a heart valve for implantation. |
申请公布号 |
US8852571(B2) |
申请公布日期 |
2014.10.07 |
申请号 |
US201213369917 |
申请日期 |
2012.02.09 |
申请人 |
Mesoblast International Sarl |
发明人 |
Pittenger Mark F.;Gordon Stephen L.;Mackay Alastair Morgan;Martin Bradley J. |
分类号 |
A61K48/00;C12N15/85;C12N5/077;C12N5/0775;A61K35/12 |
主分类号 |
A61K48/00 |
代理机构 |
McAndrews, Held & Malloy, Ltd. |
代理人 |
McAndrews, Held & Malloy, Ltd. |
主权项 |
1. A method for treating a patient with myocardial infarction comprising:
administering to the patient human allogeneic mesenchymal stem cells in an amount effective to improve cardiac function following myocardial infarction. |
地址 |
CH |